Biomechanical Assessment of Femoroacetabular Impingement
Launched by UNIVERSITY OF UTAH · Apr 11, 2012
Trial Information
Current as of July 09, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The purpose of this study is to quantify hip biomechanics of subjects with and without FAI.
The results of this study will advance our understanding of how the FAI alters the biomechanics of the hip joint, improving diagnosis and directing treatment strategies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who present with hip pain subsequently diagnosed as femoroacetabular impingement
- • Subjects who meet the following radiographic criterion of cam or pincer FAI, will be given the opportunity to volunteer in this study.
- • Subjects that demonstrate a cross-over-sign or a lateral center edge angle (LCEA) without an alpha angle, will be classified as having pincer FAI.
- • Subjects with an alpha angle, without a cross-over sign or LCEA, will be categorized as having cam type FAI.
- • Finally, with at least one cam (alpha angle) and pincer sign "cross-over-sign or a lateral center edge angle (LCEA)" will be classified as mixed FAI.
- Control Population Inclusion Criteria:
- • 12 controls will consist of volunteers in the same age range as the subject groups (18-35 years).
- • Control hips will be screened with a standard AP radiograph. Normal volunteers who have radiographic evidence of FAI, dysplasia or other joint deformities will be excluded.
- Exclusion Criteria:
- • Subjects who have radiographic evidence of osteoarthritis (Tonnis Grade III or IV) will be excluded as this study focuses on the mechanics of hips before prominent cartilage damage.
- • Subjects who have had prior procedures to correct FAI or other hip conditions will be excluded (exploratory procedures will be included).
- • Minors (under age 18), mentally disabled, persons incarcerated, on parole, probation awaiting trial, or pregnant women are excluded from this study.
- • A human Chorionic Gondaotropin (hCG) urine pregnancy test will be performed on all women prior to the study.
- • To limit the annual radiation exposure to any participating volunteers, we will exclude anyone who has had a CT scan or participated in a research study involving ionizing radiation in the past 12 months.
- Motion Capture Exclusion Criteria:
- • Subjects who are unwilling or unable to perform the proposed activities of daily living or undergo the clinical exams will be dismissed.
- • Subjects with a BMI less than 30 (www.nhlbisupport.com/bmi/) or those with dense hip musculature/wide hips (maximum of 42 cm of circumferential hip length) will be excluded.
- CT Exclusion Criteria:
- • Subjects who are unwilling or unable to remain still.
- • Subjects who are allergic to contrast agent and/or lidocaine will be dismissed.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Salt Lake, Utah, United States
Patients applied
Trial Officials
Andrew Anderson
Principal Investigator
Orthopedic Surgery Operations
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials